Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.

Charles R. Goulding and Preeti Sulibhavi explain how KKR’s investment in Henry Schein signals a transformative shift in ...

ICICI Securities recommended hold rating on HealthCare Global Enterprises with a target price of Rs 525 in its research ...

The group will purchase up to 54% of HCG’s equity at $5.14 (INR 445) per share. Global investment firm KKR has signed ...

Discover why KKR Real Estate Finance offers value with a 9% dividend yield, 24% discount to book value, and growth-focused ...

HealthCare Global share price has risen by over 2% in the past month and more than 5% on a year-to-date (YTD) basis. The ...

KKR has agreed to acquire a majority stake in Healthcare Global Enterprises, an India-based oncology hospital chain, for $400 million. The seller is CVC Capital Partners. Dr. BS Ajaikumar, founder of ...

Private equity firm KKR has agreed to acquire a controlling stake in oncology hospital chain Healthcare Global ...

India's hospital sector is experiencing a surge in deal-making, with KKR acquiring Healthcare Global for $400 million. This ...

KKR & Co. Inc. (NYSE:KKR) entered into definitive agreements with CVC, a private markets manager, to become the largest ...

As part of the deal, KKR will purchase up to 54 per cent of HCG's equity from CVC Asia V at a price of INR 445 per share.

US-based investment company KKR has agreed to acquire a stake of up to 54% in Healthcare Global Enterprises (HCG), an ...